Cingulate Inc.
CING- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001862150
No open-market purchases or sales by Cingulate Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $9.88M in total; no superinvestor holds it.
Other share classesCINGW
Q4 2024 vs. Q3 2024
How the institutions holding Cingulate Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 10 | 9 | −1 |
| Shares | 50.0K | 90.7K | +40.7K (+81.4%) |
| Value | $251.8K | $447.4K | +$195.6K (+77.7%) |
New holders (3)
Institutions that held Cingulate Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Geode Capital Management, LLC | 27,323 | $134.7K | 0.00% |
| Citigroup Inc | 387 | $1.91K | 0.00% |
| SBI Securities Co., Ltd. | 1 | $5 | 0.00% |
Sold out (4)
Institutions that held Cingulate Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Jane Street Group, LLC | 21,031 | $106.0K |
| FMR LLC | 352 | $1.77K |
| Headlands Technologies LLC | 7 | $35 |
| Royal Bank of Canada | 76 | $0 |